Who Buys Cefuroxime from India — 1458 Importers Behind a $129.6M Market
India's cefuroxime import market is served by 1458 active buyers who collectively imported $129.6M across 6,961 shipments. M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL) leads with a 7.2% market share, followed by ASCEND LABORATORIES, LLC and ASCEND LABORATORIES,LLC. The top 5 buyers together control 17.8% of total import value, reflecting a moderately competitive buyer landscape.
Top Cefuroxime Importers — Ranked by Import Value
M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL) is the leading cefuroxime importer from India, holding a 7.2% share of the $129.6M market across 6,961 shipments from 1458 buyers. The top 5 buyers — M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL), ASCEND LABORATORIES, LLC (UNITED STATES), ASCEND LABORATORIES,LLC (UNITED STATES), YUSEN LOGISTICS BENELUX BELGIUM (BELGIUM), APL SWIFT SERVICES MALTA LTD (MALTA) — collectively control 17.8% of total import value.
Top Cefuroxime Buyers & Importers
Ranked by import value · 1458 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | M/S. RANBAXY FARMACEUTICA LTDA :BRAZIL CEFUROXIME AXE. TABLETS 500MG PACK:10S SCEFTIL 250(CEFUROXIME AXETIL USP 250MG TCEFUROXIME AXE. TABLETS 500MG PACK: 10S | $9.3M | 5 | 7.2% |
| 2 | ASCEND LABORATORIES, LLCUNITED STATES CEFUROXIME AXETIL TABLETS 500MG | $4.3M | 5 | 3.4% |
| 3 | ASCEND LABORATORIES,LLCUNITED STATES CEFUROXIME AXETIL TABLETS 500MG | $3.8M | 5 | 2.9% |
| 4 | YUSEN LOGISTICS BENELUX BELGIUMBELGIUM | $3.1M | 5 | 2.4% |
| 5 | APL SWIFT SERVICES MALTA LTDMALTA CEFUROXIME AXETIL TABLETS 500MG (CEFUROXCEFUROXIME AXETIL TABLETS 500MG(CEFUROXICEFUROXIME AXETIL TABLETS 500MG CEFUROXIM PUREN 500 MG FTA | $2.5M | 5 | 2.0% |
| 6 | ASCEND LABORATORIES LLCUNITED STATES CEFUROXIME AXETIL TABLETS 500MG | $2.4M | 5 | 1.9% |
| 7 | AUROBINDO PHARMA USA., INC,UNITED STATES CEFUROXIME AXE. TABLETS 500MG PACK:10S SCEFUROXIME AXE. TABLETS 500MG PACK: 10SCEFUROXIME AXETIL TABLETS 500MG | $1.8M | 5 | 1.4% |
| 8 | AUROLOGISTICS LLC, (AUROBINDO PHARMUNITED STATES CEFUROXIME AXETIL TABLETS 500MG | $1.7M | 5 | 1.3% |
| 9 | APL SWIFT SERVICES MALTA LIMITEDMALTA CEFUROXIME AXETIL TABLETS 500MG (CEFUROXCEFUROXIME AXETIL TABLETS 500MG(CEFUROXICEFUROXIME AXETIL TABLETS 500MG CEFUROXIM PUREN 500 MG FTA | $1.6M | 5 | 1.2% |
| 10 | THE PHARMA NETWORKKAZAKHSTAN CEFTIL 250(CEFUROXIME AXETIL USP 250MG TCEFUROXIME AXETIL TABLETS 500MG (CEFUROXCEFUROXIME AXETIL TABLETS 500MG | $1.6M | 5 | 1.2% |
| 11 | FIDSON HEALTHCARE PLCNIGERIA FIDSON CEFUROXIME - 125 SUSPENSION ( CE | $1.4M | 5 | 1.1% |
| 12 | M/S. RANBAXY FARMACEUTICA LTDA.BRAZIL CEFUROXIME AXE. TABLETS 500MG PACK:10S SCEFTIL 250(CEFUROXIME AXETIL USP 250MG TCEFUROXIME AXE. TABLETS 500MG PACK: 10S | $1.4M | 5 | 1.1% |
| 13 | APL SWIFT SERVICES (MALTA) LTD.,MALTA CEFUROXIME AXETIL TABLETS 500MG (CEFUROXCEFUROXIME AXETIL TABLETS 500MG(CEFUROXICEFUROXIME AXETIL TABLETS 500MG CEFUROXIM PUREN 500 MG FTA | $1.4M | 5 | 1.1% |
| 14 | BREATHEFREE LANKA PVT LTDSRI LANKA CEFTIL 250(CEFUROXIME AXETIL USP 250MG TPHARMA PRODUCT: AUXTOCEF 500 (CEFUROXIMEPHARMA PRODUCT:AUXTOCEF 500 (CEFUROXIME | $1.4M | 5 | 1.1% |
| 15 | AUROBINDO PHARMA USA INCUNITED STATES CEFUROXIME AXE. TABLETS 500MG PACK:10S SCEFUROXIME AXE. TABLETS 500MG PACK: 10SCEFUROXIME AXETIL TABLETS 500MG | $1.3M | 5 | 1.0% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Cefuroxime — and from which countries?
Flow of Cefuroxime exports from India: each country's share and the named importers behind the numbers
Cefuroxime — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $22.0M through 246 shipments. This represents a market share of 17.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• ASCEND LABORATORIES, LLC - $4.3M (19.8% of country's total business)
• ASCEND LABORATORIES,LLC - $3.8M (17.1% of country's total business)
• ASCEND LABORATORIES LLC - $2.4M (11.0% of country's total business)
• AUROBINDO PHARMA USA., INC, - $1.8M (8.3% of country's total business)
• AUROLOGISTICS LLC, (AUROBINDO PHARM - $1.7M (7.8% of country's total business)
• Rest of United States's importers - $7.9M (36.0% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $89.4K, indicating premium pricing strategy compared to the market average of $18.6K.
United States is a key market for Cefuroxime imports, representing 17.0% of total trade value.
2Brazil
Brazil emerges as the second largest importing country, achieving a total trade value of $19.0M through 81 shipments. This represents a market share of 14.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• M/S. RANBAXY FARMACEUTICA LTDA : - $9.3M (49.0% of country's total business)
• M/S. RANBAXY FARMACEUTICA LTDA. - $1.4M (7.4% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $234.9K, indicating premium pricing strategy compared to the market average of $18.6K.
Brazil is a key market for Cefuroxime imports, representing 14.7% of total trade value.
3Philippines
Philippines emerges as the third largest importing country, achieving a total trade value of $12.9M through 0 shipments. This represents a market share of 10.0% of the total market activity, demonstrating their significant presence in the industry.
Key Insight: Philippines demonstrates strong market positioning with an average shipment value of $12.9M, indicating premium pricing strategy compared to the market average of $18.6K.
Philippines is a key market for Cefuroxime imports, representing 10.0% of total trade value.
4Nigeria
Nigeria emerges as the fourth largest importing country, achieving a total trade value of $11.3M through 21 shipments. This represents a market share of 8.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Nigeria has a diverse importer base, with their top importers including:
• FIDSON HEALTHCARE PLC - $1.4M (12.7% of country's total business)
Key Insight: Nigeria demonstrates strong market positioning with an average shipment value of $535.8K, indicating premium pricing strategy compared to the market average of $18.6K.
Nigeria is a key market for Cefuroxime imports, representing 8.7% of total trade value.
5Sri Lanka
Sri Lanka emerges as the fifth largest importing country, achieving a total trade value of $9.6M through 79 shipments. This represents a market share of 7.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Sri Lanka has a diverse importer base, with their top importers including:
• BREATHEFREE LANKA PVT LTD - $1.4M (14.4% of country's total business)
Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $121.7K, indicating premium pricing strategy compared to the market average of $18.6K.
Sri Lanka is a key market for Cefuroxime imports, representing 7.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Cefuroxime buyer market intelligence
1Buyer Segment Analysis
The importation of Cefuroxime from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: Entities like Yusen Logistics Benelux Belgium and The Pharma Network in Kazakhstan function as intermediaries, procuring large quantities of Cefuroxime for redistribution to healthcare providers and pharmacies. Their bulk purchasing leverages economies of scale, ensuring consistent supply chains.
Contract Manufacturers: Companies such as APL Swift Services Malta Ltd and APL Swift Services Malta Limited specialize in producing pharmaceuticals for other brands. They import Cefuroxime as an active pharmaceutical ingredient (API) to manufacture finished dosage forms, adhering to stringent quality standards and regulatory requirements.
Pharmaceutical Companies: Firms like M/S. Ranbaxy Farmaceutica Ltda in Brazil and Aurobindo Pharma USA, Inc. in the United States import Cefuroxime to distribute under their own branding. Their procurement strategies focus on maintaining a steady supply to meet market demand and regulatory compliance.
Country-Specific Import Regulations
TransData Nexus Cefuroxime buyer market intelligence
1Country-Specific Import Regulations
United States:
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Cefuroxime products comply with FDA regulations, including facility registration, product listing, and adherence to Current Good Manufacturing Practices (CGMP).
3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.
4. Import Tariff/Duty for HS 30042019: Pharmaceutical products under this HS code are generally duty-free in the United States.
Brazil:
1. Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
2. Import Registration Process: Importers must obtain a sanitary license, register the product with ANVISA, and comply with Brazilian pharmacopoeia standards.
3. Estimated Timeline for Registration: The process typically takes 6 to 12 months, subject to ANVISA's evaluation and any additional requirements.
4. Import Tariff/Duty for HS 30042019: Brazil imposes a standard import duty of 8% on pharmaceutical products under this HS code.
Philippines:
1. Regulatory Authority: Food and Drug Administration Philippines.
2. Import Registration Process: Importers must secure a License to Operate (LTO), register the product, and ensure compliance with local labeling and safety standards.
3. Estimated Timeline for Registration: The registration process can take approximately 6 months, depending on the completeness of the submission and regulatory review.
4. Import Tariff/Duty for HS 30042019: Pharmaceutical products under this HS code are subject to a 5% import duty in the Philippines.
Nigeria:
1. Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
2. Import Registration Process: Importers must obtain a NAFDAC registration number, provide samples for laboratory analysis, and comply with Nigerian drug labeling requirements.
3. Estimated Timeline for Registration: The process typically takes 6 to 9 months, contingent on NAFDAC's assessment and any additional documentation required.
4. Import Tariff/Duty for HS 30042019: Nigeria imposes a 5% import duty on pharmaceutical products under this HS code.
Sri Lanka:
1. Regulatory Authority: National Medicines Regulatory Authority (NMRA).
2. Import Registration Process: Importers must register the product with NMRA, provide evidence of Good Manufacturing Practice (GMP) certification, and comply with local pharmacopoeia standards.
3. Estimated Timeline for Registration: The registration process can take 6 to 12 months, depending on the completeness of the application and NMRA's review process.
4. Import Tariff/Duty for HS 30042019: Sri Lanka applies a 0% import duty on pharmaceutical products under this HS code, promoting access to essential medicines.
Demand Drivers & Market Opportunity
TransData Nexus Cefuroxime buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Cefuroxime in importing countries is driven by several factors:
1. Disease Prevalence: Cefuroxime is widely used to treat bacterial infections such as respiratory tract infections, skin infections, and urinary tract infections. High incidence rates of these conditions in various regions contribute to sustained demand.
2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the inclusion of Cefuroxime in national essential medicines lists ensures its availability in public health facilities.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential antibiotics like Cefuroxime to meet the healthcare needs of growing populations.
4. WHO Essential Medicines List Procurement: Cefuroxime's presence on the WHO Essential Medicines List underscores its importance in treating common infections, prompting countries to prioritize its procurement.
5. Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure pharmaceuticals, ensuring competitive pricing and consistent supply. This approach is prevalent in countries aiming to optimize healthcare expenditures while maintaining quality standards.
With 1,458 buyers across 150 countries, the global market for Cefuroxime presents significant opportunities for suppliers to meet diverse healthcare needs through strategic partnerships and compliance with international quality standards.
Common Questions — Cefuroxime Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest cefuroxime buyer importing from India?
Based on import volume and value, M/S. RANBAXY FARMACEUTICA LTDA : (BRAZIL) leads with $9.3M in imports and a 7.2% market share — the highest of any single cefuroxime importer. ASCEND LABORATORIES, LLC (UNITED STATES) and ASCEND LABORATORIES,LLC (UNITED STATES) are the next largest buyers.
QHow many companies buy cefuroxime from India?
There are 1458 active cefuroxime buyers importing from India, with a combined market of $129.6M across 6,961 shipments to 150 countries. The top 5 buyers hold 17.8% of total import value, while the remaining 1453 buyers handle the other 82.2%.
QWhich countries import the most cefuroxime from India?
The top importing countries for cefuroxime from India are United States (17.0%), Brazil (14.7%), Philippines (10.0%), Nigeria (8.7%), Sri Lanka (7.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of cefuroxime, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for cefuroxime from India?
The average import transaction value for cefuroxime from India is $18.6K, with an average unit price of $3.73 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Cefuroxime buyer market intelligence
1Buyer Segment Analysis
The importation of Cefuroxime from India involves various buyer segments, each with distinct purchasing behaviors and order patterns.
Distributors: Entities like Yusen Logistics Benelux Belgium and The Pharma Network in Kazakhstan function as intermediaries, procuring large quantities of Cefuroxime for redistribution to healthcare providers and pharmacies. Their bulk purchasing leverages economies of scale, ensuring consistent supply chains.
Contract Manufacturers: Companies such as APL Swift Services Malta Ltd and APL Swift Services Malta Limited specialize in producing pharmaceuticals for other brands. They import Cefuroxime as an active pharmaceutical ingredient (API) to manufacture finished dosage forms, adhering to stringent quality standards and regulatory requirements.
Pharmaceutical Companies: Firms like M/S. Ranbaxy Farmaceutica Ltda in Brazil and Aurobindo Pharma USA, Inc. in the United States import Cefuroxime to distribute under their own branding. Their procurement strategies focus on maintaining a steady supply to meet market demand and regulatory compliance.
Country-Specific Import Regulations
TransData Nexus Cefuroxime buyer market intelligence
1Country-Specific Import Regulations
United States:
1. Regulatory Authority: U.S. Food and Drug Administration (FDA).
2. Import Registration Process: Importers must ensure that Cefuroxime products comply with FDA regulations, including facility registration, product listing, and adherence to Current Good Manufacturing Practices (CGMP).
3. Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and FDA review times.
4. Import Tariff/Duty for HS 30042019: Pharmaceutical products under this HS code are generally duty-free in the United States.
Brazil:
1. Regulatory Authority: Agência Nacional de Vigilância Sanitária (ANVISA).
2. Import Registration Process: Importers must obtain a sanitary license, register the product with ANVISA, and comply with Brazilian pharmacopoeia standards.
3. Estimated Timeline for Registration: The process typically takes 6 to 12 months, subject to ANVISA's evaluation and any additional requirements.
4. Import Tariff/Duty for HS 30042019: Brazil imposes a standard import duty of 8% on pharmaceutical products under this HS code.
Philippines:
1. Regulatory Authority: Food and Drug Administration Philippines.
2. Import Registration Process: Importers must secure a License to Operate (LTO), register the product, and ensure compliance with local labeling and safety standards.
3. Estimated Timeline for Registration: The registration process can take approximately 6 months, depending on the completeness of the submission and regulatory review.
4. Import Tariff/Duty for HS 30042019: Pharmaceutical products under this HS code are subject to a 5% import duty in the Philippines.
Nigeria:
1. Regulatory Authority: National Agency for Food and Drug Administration and Control (NAFDAC).
2. Import Registration Process: Importers must obtain a NAFDAC registration number, provide samples for laboratory analysis, and comply with Nigerian drug labeling requirements.
3. Estimated Timeline for Registration: The process typically takes 6 to 9 months, contingent on NAFDAC's assessment and any additional documentation required.
4. Import Tariff/Duty for HS 30042019: Nigeria imposes a 5% import duty on pharmaceutical products under this HS code.
Sri Lanka:
1. Regulatory Authority: National Medicines Regulatory Authority (NMRA).
2. Import Registration Process: Importers must register the product with NMRA, provide evidence of Good Manufacturing Practice (GMP) certification, and comply with local pharmacopoeia standards.
3. Estimated Timeline for Registration: The registration process can take 6 to 12 months, depending on the completeness of the application and NMRA's review process.
4. Import Tariff/Duty for HS 30042019: Sri Lanka applies a 0% import duty on pharmaceutical products under this HS code, promoting access to essential medicines.
Demand Drivers & Market Opportunity
TransData Nexus Cefuroxime buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Cefuroxime in importing countries is driven by several factors:
1. Disease Prevalence: Cefuroxime is widely used to treat bacterial infections such as respiratory tract infections, skin infections, and urinary tract infections. High incidence rates of these conditions in various regions contribute to sustained demand.
2. Government Healthcare Programs: Many countries have implemented healthcare initiatives aimed at improving access to essential medicines. For instance, the inclusion of Cefuroxime in national essential medicines lists ensures its availability in public health facilities.
3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential antibiotics like Cefuroxime to meet the healthcare needs of growing populations.
4. WHO Essential Medicines List Procurement: Cefuroxime's presence on the WHO Essential Medicines List underscores its importance in treating common infections, prompting countries to prioritize its procurement.
5. Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure pharmaceuticals, ensuring competitive pricing and consistent supply. This approach is prevalent in countries aiming to optimize healthcare expenditures while maintaining quality standards.
With 1,458 buyers across 150 countries, the global market for Cefuroxime presents significant opportunities for suppliers to meet diverse healthcare needs through strategic partnerships and compliance with international quality standards.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 1458 global importers of Cefuroxime identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 6,961 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 150 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
6,961 Verified Shipments
1458 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists